Literature DB >> 12629588

Left ventricular diastolic function assessment by tissue Doppler echocardiography in relation to hormonal replacement therapy in postmenopausal women with diastolic dysfunction.

Mustafa Gökçe1, Burhan Karahan, Cevdet Erdöl, Hasan Kasap, Safak Ozdemirci.   

Abstract

The objective of this study was to evaluate the effect of hormone replacement therapy (HRT) regimens on left ventricular diastolic function by using mitral pulsed wave Doppler (MPWD) and tissue Doppler velocities (TDE). Seventy-eight postmenopausal women with normotensive and impaired diastolic left ventricular filling were included in the study. All the patients began a six-cycle HRT course. This formulation consisted of E2 valerate plus Medroxy progesterone acetate (MPA). Left ventricular diastolic function at rest was evaluated by M-mode, two-dimensional, MPWD and TDE in 78 postmenopausal women with normal blood pressure before the treatment for 6 months of HRT. The M-mode, two-dimensional, and MPWD parameters assessed were heart rate, systolic blood pressure, diastolic blood pressure, left ventricular mass index, ejection fraction of the left ventricle (EF), septal (IVS) and posterior wall (PW) thickness, left ventricular end-systolic (LVESD) and end-diastolic (LVEDD) diameter, left atrial diameter, peak early diastolic velocity (E), peak atrial velocity (A), E/A ratio, E acceleration time, E deceleration time, diastolic filling period, and isovolumic relaxation time (IVRT). The TDE parameters assessed were peak early diastolic velocity (E'), peak late diastolic velocity (A'), peak systolic velocity, E'/A' ratio, E' acceleration time, E' deceleration time, IVRT', and E/E' ratio. Quantitative data were analyzed using Student t test. Among the MPWD parameters, peak A velocity, E deceleration time, and IVRT significantly decreased, while peak E velocity and E/A ratio increased after a 6-month treatment. From the point of TDE parameters, E' velocity and E'/A' ratio increased, while A' velocity, E' deceleration time, E/E' ratio and IVRT' decreased. Some MPWD and TDE parameters were partially reversed after HRT. TDE velocities and especially E/E' ratio may provide better and true information of the diastolic function. TDE parameters were independent from the preload and did not produce pseudonormal pattern. HRT may cause increase in the blood volume and produce pseudonormal pattern in transmitral flow. In that case, TDE may be a beneficial method for evaluation of diastolic function.

Entities:  

Mesh:

Year:  2003        PMID: 12629588     DOI: 10.1097/00045391-200303000-00005

Source DB:  PubMed          Journal:  Am J Ther        ISSN: 1075-2765            Impact factor:   2.688


  5 in total

1.  Comparison of the effects of new and conventional hormone replacement therapies on left ventricular diastolic function in healthy postmenopausal women: a Doppler and ultrasonic backscatter study.

Authors:  Hamza Duygu; Levent Akman; Filiz Ozerkan; Fuat Akercan; Mehdi Zoghi; Sanem Nalbantgil; Umit Erturk; Azem Akilli; Remzi Onder; Mustafa Akin
Journal:  Int J Cardiovasc Imaging       Date:  2009-02-05       Impact factor: 2.357

Review 2.  The Role of Estrogen in Cardiac Metabolism and Diastolic Function.

Authors:  Shumin Li; Anisha A Gupte
Journal:  Methodist Debakey Cardiovasc J       Date:  2017 Jan-Mar

Review 3.  Sex Differences in Molecular Mechanisms of Cardiovascular Aging.

Authors:  Vanessa Dela Justina; Jéssica S G Miguez; Fernanda Priviero; Jennifer C Sullivan; Fernanda R Giachini; R Clinton Webb
Journal:  Front Aging       Date:  2021-09-10

4.  Age-related sex differences in the outcomes of patients with hypertrophic cardiomyopathy.

Authors:  Hyun-Jung Lee; Hyung-Kwan Kim; Sang Chol Lee; Steve R Ommen; Jihoon Kim; Jun-Bean Park; You-Jung Choi; Seung-Pyo Lee; Sung-A Chang; Yong-Jin Kim
Journal:  PLoS One       Date:  2022-02-25       Impact factor: 3.240

5.  Echocardiographic assessment of inappropriate left ventricular mass and left ventricular hypertrophy in patients with diastolic dysfunction.

Authors:  Hasan Shemirani; Rohola Hemmati; Alireza Khosravi; Mojgan Gharipour; Mahnaz Jozan
Journal:  J Res Med Sci       Date:  2012-02       Impact factor: 1.852

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.